Published in Respirology on February 01, 2010
European union standards for tuberculosis care. Eur Respir J (2012) 1.73
Latent tuberculosis: what the host "sees"? Immunol Res (2011) 1.35
Comparison of the efficacies of loop-mediated isothermal amplification, fluorescence smear microscopy and culture for the diagnosis of tuberculosis. PLoS One (2011) 1.24
Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons? PLoS One (2010) 1.18
Retracted Diagnosis and management of miliary tuberculosis: current state and future perspectives. Ther Clin Risk Manag (2013) 1.13
IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy. BMC Infect Dis (2011) 1.12
Evolution of drug resistance in tuberculosis: recent progress and implications for diagnosis and therapy. Drugs (2014) 0.94
Complicated urinary infection and extrapulmonary tuberculosis. BMJ Case Rep (2012) 0.89
Comparison of a DNA Based PCR Approach with Conventional Methods for the Detection of Mycobacterium tuberculosis in Morocco. Mediterr J Hematol Infect Dis (2012) 0.85
HIV and tuberculosis trends in the United States and select Sub-Saharan Africa countries. Int J Environ Res Public Health (2011) 0.79
Accuracy of the Bronchoalveolar Lavage Enzyme-Linked Immunospot Assay for the Diagnosis of Pulmonary Tuberculosis: A Meta-analysis. Medicine (Baltimore) (2016) 0.78
Improved polyacrylamide-based artificial sputum with formalin-fixed tubercle bacilli for training of tuberculosis microscopists. J Clin Microbiol (2011) 0.78
Extrapulmonary tuberculosis: importance of differential diagnosis. BMJ Case Rep (2011) 0.78
Can ELISPOT Be Applied to A Clinical Setting as A Diagnostic Utility for Neuroborreliosis? Cells (2012) 0.78
Cytokine and Antibody Based Diagnostic Algorithms for Sputum Culture-Positive Pulmonary Tuberculosis. PLoS One (2015) 0.78
The Use of Interferon Gamma Inducible Protein 10 as a Potential Biomarker in the Diagnosis of Latent Tuberculosis Infection in Uganda. PLoS One (2016) 0.77
Tuberculosis diagnostics: Challenges and opportunities. Lung India (2012) 0.75
Performance of point-of-care urine test in diagnosing tuberculosis suspects with and without HIV infection in selected peripheral health settings of Addis Ababa, Ethiopia. BMC Res Notes (2017) 0.75
Serum amyloid A, protein Z, and C4b-binding protein β chain as new potential biomarkers for pulmonary tuberculosis. PLoS One (2017) 0.75
The Value of Bronchoalveolar Lavage in the Diagnosis of Sputum Smear-NegativePulmonary Tuberculosis. Iran J Pathol (2015) 0.75
Comparative evaluation of TK SLC-L, a rapid liquid mycobacterial culture medium, with the MGIT system. BMC Infect Dis (2014) 0.75
Tuberculosis in Solid Organ Transplantation. Tanaffos (2016) 0.75
Evaluation of immunological parameters in purified protein derivative positive tuberculin workers. Iran J Basic Med Sci (2013) 0.75
A case of preventable pulmonary tuberculosis in a Greenlandic, heavily immune suppressed patient. Respir Med Case Rep (2011) 0.75
Defining the research agenda to reduce the joint burden of disease from diabetes mellitus and tuberculosis. Trop Med Int Health (2010) 2.35
Detection of multidrug resistance in Mycobacterium tuberculosis. J Clin Microbiol (2006) 2.06
Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol (2006) 1.74
Challenges to the global control of tuberculosis. Respirology (2013) 1.40
Correlation between suspended particles in the environmental air and causes of disease among inhabitants: cross-sectional studies using the vital statistics and air pollution data in Japan. Environ Res (2005) 1.38
Interferon-gamma responses after isoniazid chemotherapy for latent tuberculosis. Respirology (2008) 1.26
Development and evaluation of a line probe assay for rapid identification of pncA mutations in pyrazinamide-resistant mycobacterium tuberculosis strains. J Clin Microbiol (2007) 1.22
Comparison of the sensitivity and specificity of two whole blood interferon-gamma assays for M. tuberculosis infection. J Infect (2008) 1.13
Use of QuantiFERON-TB Gold to investigate tuberculosis contacts in a high school. Respirology (2007) 1.12
Relationship between whole-blood interferon-gamma responses and the risk of active tuberculosis. Tuberculosis (Edinb) (2008) 1.07
A revaluation of folliculosebaceous cystic hamartoma: the histopathological and immunohistochemical features. Am J Dermatopathol (2010) 0.99
Identification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother (2010) 0.99
A revaluation of trichofolliculoma: the histopathological and immunohistochemical features. Am J Dermatopathol (2010) 0.96
Computerized surveillance system of tuberculosis in Japan: its evolution, achievement and challenges. Kekkaku (2012) 0.94
Diagnosis of active tuberculous serositis by antigen-specific interferon-gamma response of cavity fluid cells. Clin Infect Dis (2007) 0.93
Downregulation of katG expression is associated with isoniazid resistance in Mycobacterium tuberculosis. Mol Microbiol (2011) 0.90
Comprehensive multicenter evaluation of a new line probe assay kit for identification of Mycobacterium species and detection of drug-resistant Mycobacterium tuberculosis. J Clin Microbiol (2012) 0.89
[Usefulness of QuantiFERON TB-2G in contact investigation of a tuberculosis outbreak in a university]. Kekkaku (2005) 0.88
Evaluation of a line probe assay for the rapid detection of gyrA mutations associated with fluoroquinolone resistance in multidrug-resistant Mycobacterium tuberculosis. J Med Microbiol (2010) 0.86
Performance of a Whole-Blood Interferon-Gamma Release Assay with Mycobacterium RD1-Specific Antigens among HIV-Infected Persons. Clin Dev Immunol (2010) 0.85
Evaluation of major membrane protein-II as a tool for serodiagnosis of leprosy. FEMS Microbiol Lett (2007) 0.82
[Variation in yield of needle scars with multipuncture BCG vaccination]. Nihon Koshu Eisei Zasshi (2005) 0.82
Comparison of performance in two diagnostic methods for tuberculosis infection. Med Microbiol Immunol (2008) 0.80
Transmission of specific genotype streptomycin resistant strains of Mycobacterium tuberculosis in the Tokyo Metropolitan Area in Japan. BMC Infect Dis (2009) 0.80
[Effects of prophylaxis on QuantiFERON TB-2G responses among children]. Kekkaku (2008) 0.79
[Frequency of MDR-TB/XDR-TB strains isolated from chronic pulmonary tuberculosis patients in Japan]. Kekkaku (2007) 0.79
[Utility of QuantiFERON TB-2G for tuberculosis contact investigations in public health services]. Nihon Koshu Eisei Zasshi (2007) 0.78
Analysis of an interferon-gamma release assay for monitoring the efficacy of anti-tuberculosis chemotherapy. Jpn J Infect Dis (2011) 0.77
Pulmonary hilar lymph nodes in lung cancer: assessment with 3D-dynamic contrast-enhanced MR imaging. Eur J Radiol (2003) 0.76
[Usefulness of a novel diagnostic method of tuberculosis infection, QuantiFERON TB-2G, in an outbreak of tuberculosis]. Kekkaku (2004) 0.76
Microepidemics of tuberculosis revealed by DNA-fingerprinting of M. tuberculosis. Intern Med (2004) 0.75
[Tuberculosis in the patients undergoing haemodialysis in Japan, 1996]. Kekkaku (2002) 0.75
Survey of human immunodeficiency virus (HIV)-seropositive patients with mycobacterial infection in Japan. J Infect (2005) 0.75
[Investigation on preventive measures of tuberculosis infection and onset of tuberculosis in nursing homes for the aged]. Kekkaku (2002) 0.75
[NINETY YEARS OF THE JAPANESE SOCIETY FOR TUBERCULOSIS--Back to the Future for Research and Control of Tuberculosis]. Kekkaku (2015) 0.75
Assessment of nosocomial transmission of tuberculosis in a psychiatric hospital using a whole blood interferon-gamma assay. Jpn J Infect Dis (2008) 0.75
[A new anti-mycobacterial agent, rifabutin]. Kekkaku (2010) 0.75
[The present situation of daily life of tuberculosis patients treated in hospitals with beds for tuberculosis in Japan]. Kekkaku (2002) 0.75
Congenital myofibroma of the skin mimicking a piloleiomyoma. J Cutan Pathol (2009) 0.75
[A survey on the onset of tuberculosis in nursing homes]. Kekkaku (2003) 0.75
[The East Japan Earthquake and tsunami disaster and tuberculosis]. Kekkaku (2011) 0.75
[Contact investigation using QuantiFERON-TB Gold test to evaluate TB exposure in 61 subjects in a hospital setting--(1) Outline of the outbreak and its clinical picture]. Kekkaku (2012) 0.75
[Prevention of nosocomial infection of tuberculosis]. Nihon Rinsho (2003) 0.75
[Relationship between BCG immunization coverage and the immunization delivery system in the Tama area of Tokyo]. Kansenshogaku Zasshi (2012) 0.75
Evaluation of a 1 step TRAb assay for the detection of high-affinity components to hTSHR: evidences indicating superiority of the assay in the lower TRAb range. Endocr J (2006) 0.75
[Detection of tuberculosis infection using a whole blood interferon gamma assay in a contact investigation--evaluation using quantiFERon TB-2G]. Kekkaku (2005) 0.75
[Analysis of tuberculosis infection among foreigners using QuantiFeron TB-2G test]. Kekkaku (2007) 0.75
[Progress in the field of pulmonary medicine in the last 100 years: Mass screening for tuberculosis]. Nihon Naika Gakkai Zasshi (2002) 0.75
Differences in TSH receptor binding and thyroid-stimulating properties between TSH and Graves' IgG. Slowly-acting TSH receptor antibody moieties in Graves' sera affect assay data. Endocr J (2005) 0.75
[Usefulness of QuantiFERONTB-2G in a suspected case of drug resistant tuberculosis outbreak in a university]. Kekkaku (2008) 0.75
[Considerations on uses of newly developed anti-tuberculosis drugs for multi-drug resistant tuberculosis]. Kekkaku (2014) 0.75
Accuracy of LAMP-TB Method for Diagnosing Tuberculosis in Haiti. Jpn J Infect Dis (2016) 0.75
[Comparison of conventional tuberculin skin test and QFT-2G, a new method for diagnosis of tuberculosis infection, with the use of the contact score]. Kekkaku (2011) 0.75